CANGRELOR for Percutaneous coronary intervention: Side Effects & Safety Data

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

There are 94 adverse event reports in the FDA FAERS database where CANGRELOR was used for Percutaneous coronary intervention.

Most Reported Side Effects for CANGRELOR

Side Effect	Reports	%	Deaths	Hosp.
Off label use	144	44.6%	25	9
Vascular stent thrombosis	29	9.0%	4	1
Drug ineffective	26	8.1%	3	13
Haemorrhage	22	6.8%	6	5
Death	19	5.9%	19	0
No adverse event	19	5.9%	0	0
Inappropriate schedule of product administration	18	5.6%	5	3
Cardiac arrest	15	4.6%	8	0
Cardiogenic shock	14	4.3%	11	3
Gastrointestinal haemorrhage	12	3.7%	2	6
Intentional product use issue	11	3.4%	1	1
Drug ineffective for unapproved indication	9	2.8%	2	0
Dyspnoea	9	2.8%	1	0
Haemorrhage intracranial	9	2.8%	3	2
Vascular access site haemorrhage	9	2.8%	3	1